- Home
- CHRO vs LDWY Comparison
CHRO vs LDWY Comparison
Compare CHRO & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRO
- LDWY
- Stock Information
- Founded
- CHRO 2002
- LDWY 1990
- Country
- CHRO United States
- LDWY United States
- Employees
- CHRO N/A
- LDWY N/A
- Industry
- CHRO
- LDWY Advertising
- Sector
- CHRO
- LDWY Consumer Discretionary
- Exchange
- CHRO Nasdaq
- LDWY Nasdaq
- Market Cap
- CHRO 8.1M
- LDWY 6.7M
- IPO Year
- CHRO 2024
- LDWY 1991
- Fundamental
- Price
- CHRO $1.37
- LDWY $4.12
- Analyst Decision
- CHRO Strong Buy
- LDWY
- Analyst Count
- CHRO 1
- LDWY 0
- Target Price
- CHRO N/A
- LDWY N/A
- AVG Volume (30 Days)
- CHRO 2.1M
- LDWY 3.9K
- Earning Date
- CHRO 05-14-2025
- LDWY 05-19-2025
- Dividend Yield
- CHRO N/A
- LDWY N/A
- EPS Growth
- CHRO N/A
- LDWY N/A
- EPS
- CHRO N/A
- LDWY N/A
- Revenue
- CHRO N/A
- LDWY $37,773,000.00
- Revenue This Year
- CHRO N/A
- LDWY N/A
- Revenue Next Year
- CHRO N/A
- LDWY N/A
- P/E Ratio
- CHRO N/A
- LDWY N/A
- Revenue Growth
- CHRO N/A
- LDWY N/A
- 52 Week Low
- CHRO $0.45
- LDWY $3.02
- 52 Week High
- CHRO $3.80
- LDWY $6.44
- Technical
- Relative Strength Index (RSI)
- CHRO 46.67
- LDWY 62.30
- Support Level
- CHRO $1.29
- LDWY $3.70
- Resistance Level
- CHRO $1.65
- LDWY $4.23
- Average True Range (ATR)
- CHRO 0.20
- LDWY 0.18
- MACD
- CHRO 0.02
- LDWY 0.05
- Stochastic Oscillator
- CHRO 13.81
- LDWY 56.24
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.